SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias
Clinical trial NCT03801889 · WITHDRAWN
Trial details
- NCT number
- NCT03801889
- Sponsor
- Abfero Pharmaceuticals, Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2022-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.